ChristianaCare

All visitors are required to wear masks.

For COVID-19 safety, all visitors to ChristianaCare facilities and services are required to wear masks. This includes visitors who are vaccinated. Please read our visitor guidelines before arrival.

Masks required at outpatient locations; visitors and support persons limited

All visitors at outpatient locations must be masked in alignment with the masking guidelines on our visitation policy page here. Patients at ChristianaCare’s outpatient services are advised to come to their appointments alone unless a support person is absolutely needed. If a support person is needed, such as a parent, guardian or spokesperson, we highly encourage that the support person be vaccinated. Outpatient practices are not requiring vaccination or a negative COVID test for visitors at this time.

All hospital visitors required to be vaccinated or have a negative COVID-19 test.

  • Inpatients in our Christiana, Wilmington and Union hospitals may have one visitor daily between 10 a.m. and 8 p.m. The visitor must be 16 or older.
  • Patients having outpatient surgery may have one support person accompany them. Support persons must be 16 or older.
  • All visitors and surgical support people must show proof of vaccination OR a negative COVID-19 test within the prior 72 hours.

Before visiting, click here for more details about visitation.

Visit coronavirus.delaware.gov or cecilcountyhealth.org for local vaccination and testing sites.

Cancer Research at the
Helen F. Graham Cancer Center
& Research Institute

Oncology Patient Advocates for Clinical Trials (OPACT)

Oncology Patient Advocates for Clinical Trials (OPACT) is a group of cancer survivors who have participated in clinical trials and seek to help other patients who may be considering clinical trials. We build bridges between patients, physicians, nurses, social workers and others who provide care to cancer patients considering participation in a Helen F. Graham Cancer Center & Research Institute clinical trial.

Mission & Vision

Our goal is to create awareness of the opportunities patients have in the clinical trial program. We will serve as a resource for both new patients considering clinical trials, and clinical trial practitioners to improve the the overall experience for the patient. We will communicate the trial results to patients once available and also celebrate our patients’ accomplishments through an annual event.

What is a Clinical Trial?

A clinical trial is a research study designed to answer a specific scientific question. Research clinical trials are conducted with cancer patients to determine if a new treatment or therapy is effective. Treatments can include surgery, radiation therapy and chemotherapy, either alone or in combination.

Some clinical trials are designed to study ways to prevent cancer. They are called prevention trials. Other studies examine the psychological impact of cancer, ways to improve patient quality of life, and ways to control symptoms or side effects. A clinical trial is often referred to as a protocol.

The cancer clinical trials available through the Helen F. Graham Center & Research Institute are sponsored by the National Cancer Institute (NCI) and other national research partners. The ChristianaCare cancer research program is a NCI Community Oncology Research Program (NCORP). As a NCORP member, the Helen F. Graham Cancer Center & Research Institute provides patients with the newest cancer therapies, including more than 100 clinical trials sponsored by the federal government and drug companies for the prevention and treatment of cancer at different stages.

How We Can Help

We understand what you’re going through because we’ve been there. We know how overwhelming these decisions about treating your cancer can feel. The good news is that you have options. Clinical trials offer you access to new treatments that might otherwise be unavailable.

You also have us. We are your advocates. We can help ease the burden of making these decisions by sharing our knowledge and experience with clinical studies. We know that from a patient’s perspective the more information you have, the easier it will be for you and your family to make the decision that’s right for you.

To talk with one of us, call the cancer research office at 302-623-4450.

Cancer Research Program
Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Suite 2200, Newark, DE 19713 directions
For more information, call 302-623-4450 or e-mail us.